Mutations in SCN3A cause early infantile epileptic encephalopathy

Voltage‐gated sodium (Na+) channels underlie action potential generation and propagation and hence are central to the regulation of excitability in the nervous system. Mutations in the genes SCN1A, SCN2A, and SCN8A, encoding the Na+ channel pore‐forming (α) subunits Nav1.1, 1.2, and 1.6, respectively, and SCN1B, encoding the accessory subunit β1, are established causes of genetic epilepsies. SCN3A, encoding Nav1.3, is known to be highly expressed in brain, but has not previously been linked to early infantile epileptic encephalopathy. Here, we describe a cohort of 4 patients with epileptic encephalopathy and heterozygous de novo missense variants in SCN3A (p.Ile875Thr in 2 cases, p.Pro1333Leu, and p.Val1769Ala).

[1]  L. Lagae,et al.  Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN 2 A-related disorders , 2017 .

[2]  G. Carvill,et al.  Not all SCN1A epileptic encephalopathies are Dravet syndrome , 2017, Neurology.

[3]  F. Bezanilla,et al.  Domain IV voltage-sensor movement is both sufficient and rate limiting for fast inactivation in sodium channels , 2013, The Journal of general physiology.

[4]  Lingjia Tang,et al.  Alteration of Scn3a expression is mediated via CpG methylation and MBD2 in mouse hippocampus during postnatal development and seizure condition. , 2015, Biochimica et biophysica acta.

[5]  B. Vazquez,et al.  A Case of Extended Spectrum GEFS+ , 2005, Epilepsia.

[6]  A. L. Goldin,et al.  A gain-of-function mutation in the sodium channel gene Scn2a results in seizures and behavioral abnormalities , 2001, Neuroscience.

[7]  William A Catterall,et al.  Voltage‐gated sodium channels at 60: structure, function and pathophysiology , 2012, The Journal of physiology.

[8]  M. Gutnick,et al.  Slow inactivation of Na+ current and slow cumulative spike adaptation in mouse and guinea‐pig neocortical neurones in slices. , 1996, The Journal of physiology.

[9]  S. Dib-Hajj,et al.  A sodium channel mutation linked to epilepsy increases ramp and persistent current of Nav1.3 and induces hyperexcitability in hippocampal neurons , 2010, Experimental Neurology.

[10]  Z. Zong,et al.  Voltage-gated sodium channel Nav1.1, Nav1.3 and β1 subunit were up-regulated in the hippocampus of spontaneously epileptic rat , 2008, Brain Research Bulletin.

[11]  Jeffrey J. Clare,et al.  The Sodium Channel β3-Subunit Induces Multiphasic Gating in NaV1.3 and Affects Fast Inactivation via Distinct Intracellular Regions , 2010, The Journal of Biological Chemistry.

[12]  C. Stafstrom.  Persistent Sodium Current and Its Role in Epilepsy , 2007, Epilepsy currents.

[13]  W. Catterall,et al.  From Ionic Currents to Molecular Mechanisms The Structure and Function of Voltage-Gated Sodium Channels , 2000, Neuron.

[14]  B. Bean,et al.  Subthreshold Sodium Currents and Pacemaking of Subthalamic Neurons Modulation by Slow Inactivation , 2003, Neuron.

[15]  Yong-hui Jiang,et al.  Genetic Variants Identified from Epilepsy of Unknown Etiology in Chinese Children by Targeted Exome Sequencing , 2017, Scientific Reports.

[16]  A. George,et al.  Novel SCN3A variants associated with focal epilepsy in children , 2014, Neurobiology of Disease.

[17]  Rolf Schröder,et al.  Clinical exome sequencing: results from 2819 samples reflecting 1000 families , 2016, European Journal of Human Genetics.

[18]  L. Lagae,et al.  Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders , 2017, Brain : a journal of neurology.

[19]  I. Lampl,et al.  Reduction of cortical pyramidal neuron excitability by the action of phenytoin on persistent Na+ current. , 1998, The Journal of pharmacology and experimental therapeutics.

[20]  Stephen G. Waxman,et al.  Upregulation of persistent and ramp sodium current in dorsal horn neurons after spinal cord injury , 2006, Experimental Brain Research.

[21]  E. Wirrell.  Treatment of Dravet Syndrome , 2016, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[22]  Massimo Mantegazza,et al.  Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders , 2010, The Lancet Neurology.

[23]  J. Hoeijmakers,et al.  Efficacy, safety, and tolerability of lacosamide in patients with gain-of-function Nav1.7 mutation-related small fiber neuropathy: study protocol of a randomized controlled trial–the LENSS study , 2016, Trials.

[24]  J. Noebels.  Predicting the impact of sodium channel mutations in human brain disease , 2019, Epilepsia.

[25]  H. Beck,et al.  Activity of the anticonvulsant lacosamide in experimental and human epilepsy via selective effects on slow Na+ channel inactivation , 2017, Epilepsia.

[26]  M Montal,et al.  A missense mutation of the Na+ channel αII subunit gene Nav1.2 in a patient with febrile and afebrile seizures causes channel dysfunction , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[27]  S. Dib-Hajj,et al.  Sodium channel α-subunit mRNAs I, II, III, NaG, Na6 and hNE (PN1): Different expression patterns in developing rat nervous system , 1997 .

[28]  B. Bean,et al.  Lacosamide Inhibition of Nav1.7 Voltage-Gated Sodium Channels: Slow Binding to Fast-Inactivated States , 2017, Molecular Pharmacology.

[29]  C. Walsh,et al.  Somatic mutations in cerebral cortical malformations. , 2014, The New England journal of medicine.

[30]  M. Meisler,et al.  Mutation of sodium channel SCN3A in a patient with cryptogenic pediatric partial epilepsy , 2008, Neuroscience Letters.

[31]  E. Campbell,et al.  Voltage Sensor of Kv1.2: Structural Basis of Electromechanical Coupling , 2005, Science.

[32]  A. Alonso,et al.  Biophysical Properties and Slow Voltage-Dependent Inactivation of a Sustained Sodium Current in Entorhinal Cortex Layer-II Principal Neurons , 1999, The Journal of general physiology.

[33]  Mei-Mei Gao,et al.  Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A , 2014, Molecular Neurobiology.

[34]  S. Liang,et al.  Synergetic Action of Domain II and IV Underlies Persistent Current Generation in Nav1.3 as revealed by a tarantula toxin , 2015, Scientific Reports.

[35]  G. Stuart,et al.  Voltage–activated sodium channels amplify inhibition in neocortical pyramidal neurons , 1999, Nature Neuroscience.

[36]  Y. H. Chen,et al.  Distribution of voltage-gated sodium channel alpha-subunit and beta-subunit mRNAs in human hippocampal formation, cortex, and cerebellum. , 2000, The Journal of comparative neurology.

[37]  P. Striano,et al.  Co‐occurring malformations of cortical development and SCN1A gene mutations , 2014, Epilepsia.

[38]  Jianping Wu,et al.  Structure of a eukaryotic voltage-gated sodium channel at near-atomic resolution , 2017, Science.

[39]  T. Cummins,et al.  Differential Block of Sensory Neuronal Voltage-Gated Sodium Channels by Lacosamide [(2R)-2-(Acetylamino)-N-benzyl-3-methoxypropanamide], Lidocaine, and Carbamazepine , 2008, Journal of Pharmacology and Experimental Therapeutics.

[40]  A. Sayad,et al.  Epilepsy Is Associated With Dysregulation of Long Non-coding RNAs in the Peripheral Blood , 2019, Front. Mol. Biosci..

[41]  L. Lagae,et al.  De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. , 2001, American journal of human genetics.

[42]  G. Carvill,et al.  The phenotypic spectrum of SCN8A encephalopathy , 2015, Neurology.

[43]  W. Crill,et al.  Persistent sodium current in mammalian central neurons. , 1996, Annual review of physiology.

[44]  James O. Jackson,et al.  Human voltage-gated sodium channel mutations that cause inherited neuronal and muscle channelopathies increase resurgent sodium currents. , 2010, The Journal of clinical investigation.

[45]  S. Waxman,et al.  Upregulation of Sodium Channel Nav1.3 and Functional Involvement in Neuronal Hyperexcitability Associated with Central Neuropathic Pain after Spinal Cord Injury , 2003, The Journal of Neuroscience.

[46]  Jeffrey J. Clare,et al.  Distribution of voltage‐gated sodium channel α‐subunit and β‐subunit mRNAs in human hippocampal formation, cortex, and cerebellum , 2000 .

[47]  E. Wirrell,et al.  Optimizing the Diagnosis and Management of Dravet Syndrome: Recommendations From a North American Consensus Panel. , 2017, Pediatric Neurology.

[48]  Berten Ceulemans,et al.  De novo SCN1A mutations are a major cause of severe myoclonic epilepsy of infancy , 2003, Human mutation.

[49]  A. George,et al.  Single-channel Properties of Human NaV1.1 and Mechanism of Channel Dysfunction in SCN1A-associated Epilepsy , 2006, The Journal of general physiology.

[50]  Stacey B. B. Dutton,et al.  SCN3A deficiency associated with increased seizure susceptibility , 2017, Neurobiology of Disease.

[51]  G Avanzini,et al.  Layer-specific properties of the persistent sodium current in sensorimotor cortex. , 2006, Journal of neurophysiology.

[52]  S. McMahon,et al.  Nerve injury induces robust allodynia and ectopic discharges in Nav1.3 null mutant mice , 2006, Molecular pain.

[53]  Anup D. Patel,et al.  GRIN2B encephalopathy: novel findings on phenotype, variant clustering, functional consequences and treatment aspects , 2017, Journal of Medical Genetics.

[54]  Stephen G. Waxman,et al.  International Union of Pharmacology. XXXIX. Compendium of Voltage-Gated Ion Channels: Sodium Channels , 2003, Pharmacological Reviews.

[55]  A. L. Goldin.  Mechanisms of sodium channel inactivation , 2003, Current Opinion in Neurobiology.

[56]  D. Lindhout,et al.  Remarkable Phenytoin Sensitivity in 4 Children with SCN8A-related Epilepsy: A Molecular Neuropharmacological Approach , 2015, Neurotherapeutics.

[57]  M. Noda,et al.  Differential regulation of three sodium channel messenger RNAs in the rat central nervous system during development. , 1989, The EMBO journal.

[58]  W. Catterall,et al.  Correlations in timing of sodium channel expression, epilepsy, and sudden death in Dravet syndrome , 2013, Channels.

[59]  K. Veeramah,et al.  De novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP. , 2012, American journal of human genetics.

[60]  L. Isom,et al.  Sodium channel β subunits: emerging targets in channelopathies. , 2015, Annual review of physiology.

[61]  G. Avanzini,et al.  Phenytoin Inhibits the Persistent Sodium Current in Neocortical Neurons by Modifying Its Inactivation Properties , 2013, PloS one.

[62]  W. Wadman,et al.  Carbamazepine and Topiramate Modulation of Transient and Persistent Sodium Currents Studied in HEK293 Cells Expressing the Nav1.3 α–Subunit , 2007, Epilepsia.